>>  Home  >>  Scientific Publications  >>  2018



Scientific Publications

Medical Library

Business Opportunities


Education & Training

Biological Safety

Unified Culture Collection

Special Pathogens Lab

Reference Materials

Related Links


Contact Us



— 2019—

Abudurexiti A, Adkins S, Alioto D, et al. Taxonomy of the order Bunyavirales: update 2019. Arch Virol. 2019;164(7):1949-1965. https://doi.org/10.1007/s00705-019-04253-6

Amarasinghe GK, Ayllón MA, Bào Y, et al. Taxonomy of the order Mononegavirales: update 2019. Arch Virol. 2019;164(7):1967-1980. https://doi.org/10.1007/s00705-019-04247-4

Arnold CE, Guito JC, Altamura LA, et al. Transcriptomics reveal antiviral gene induction in the Egyptian rousette bat is antagonized in vitro by Marburg virus infection. Viruses. 2018;10(11):607. https://doi.org/10.3390/v10110607

Atre T, Phillips RL, Modjarrad K, Regules JA, Bergmann-Leitner ES. Development and characterization of a Zaire Ebola (ZEBOV) specific IgM ELISA. J Immunol Methods. 2019;468:29-34. https://doi.org/10.1016/j.jim.2019.03.008

Bachert BA, Biryukov SS, Chua J, et al. A Francisella novicida mutant, lacking the soluble lytic transglycosylase slt, exhibits defects in both growth and virulence. Front Microbiol. 2019;10:1343. https://doi.org/10.3389/fmicb.2019.01343

Bazzill JD, Stronsky SM, Kalinyak LC, et al. Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses. Nanomedicine. 2019;18:414-425. https://doi.org/10.1016/j.nano.2018.11.005

Blair PW, Keshtkar-Jahromi M, Psoter KJ, et al. Virulence of Marburg virus Angola compared to Mt. Elgon (Musoke) in macaques: a pooled survival analysis. Viruses. 2018;10(11):658. https://doi.org/10.3390/v10110658

Blair PW, Kuhn JH, Pecor DB, et al. An emerging biothreat: Crimean-Congo hemorrhagic fever virus in Southern and Western Asia. Am J Trop Med Hyg. 2019;100(1):16-23. https://doi.org/10.4269/ajtmh.18-0553

Bocan TM, Basuli F, Stafford RG, et al. Synthesis of [ 18 F] favipiravir and biodistribution in C3H/HeN mice as assessed by positron emission tomography. Sci Rep. 2019;9(1):1785. https://doi.org/10.1038/s41598-018-37866-z

Bornholdt ZA, Herbert AS, Mire CE, et al. A two-antibody pan-Ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates. Cell Host Microbe. 2019;25(1):49-58.e45. https://doi.org/10.1016/j.chom.2018.12.005

Bose ME, Shrivastava S, He J, et al. Sequencing and analysis of globally obtained human parainfluenza viruses 1 and 3 genomes. PLoS One. 2019;14(7):e0220057. https://doi.org/10.1371/journal.pone.0220057

Brannan JM, He S, Howell KA, et al. Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates. Nat Commun. 2019;10(1):105. https://doi.org/10.1038/s41467-018-08040-w

Brocato RL, Hooper JW. Progress on the prevention and treatment of hantavirus disease. Viruses. 2019;11(7):610. https://doi.org/10.3390/v11070610

Bruhn M, Schindler D, Kemter FS, et al. Functionality of two origins of replication in vibrio cholerae strains with a single chromosome. Front Microbiol. 2018;9:2932. https://doi.org/10.3389/fmicb.2018.02932

Caì Y, Iwasaki M, Beitzel BF, et al. Recombinant Lassa virus expressing green fluorescent protein as a tool for high-throughput drug screens and neutralizing antibody assays. Viruses. 2018;10(11):655. https://doi.org/10.3390/v10110655

Caì Y, Yú S, Jangra RK, et al. Human, nonhuman primate, and bat cells are broadly susceptible to tibrovirus particle cell entry. Front Microbiol. 2019;10:856. https://doi.org/10.3389/fmicb.2019.00856

Cai YY, Iwasaki M, Beitzel BF, et al. Recombinant Lassa virus expressing green fluorescent protein as a tool for high-throughput drug screens and neutralizing antibody assays. Viruses. 2018;10(11):655. https://doi.org/10.3390/v10110655

Cashman KA, Wilkinson ER, Zeng X, et al. Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following Lassa virus exposure in cynomolgus macaques. mBio. 2018;9(5):e01896-18. https://doi.org/10.1128/mBio.01896-18

Chua J, Bozue JA, Klimko CP, et al. Formaldehyde and glutaraldehyde inactivation of bacterial tier 1 select agents in tissues. Emerg Infect Dis. 2019;25(5):919-926. https://doi.org/10.3201/eid2505.180928

Clements TL, Rossi CA, Irish AK, et al. Chikungunya and O'nyong-nyong viruses in Uganda: implications for diagnostics. Open Forum Infect Dis. 2019;6(3): ofz001. https://doi.org/10.1093/ofid/ofz001

Conrad TA, Lo CC, Koehler JW, et al. Diagnostic targETEd seQuencing adjudicaTion (DETEQT) algorithms for adjudicating targeted infectious disease next-generation sequencing panels. J Mol Diagn. 2019;21(1):99-110. https://doi.org/10.1016/j.jmoldx.2018.08.008

Cooper TK, Huzella L, Johnson JC, et al. Author Correction: histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model. Sci Rep. 2019;9(1):15013. https://doi.org/10.1038/s41598-019-51386-4

DeShazer D. A novel contact-independent T6SS that maintains redox homeostasis via Zn2+ and Mn2+ acquisition is conserved in the Burkholderia pseudomallei complex. Microbiol Res. 2019;226:48-54. https://doi.org/10.1016/j.micres.2019.05.007

DeShazer D, Lovett S, Richardson J, et al. Bacteriophage-associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848. J Med Microbiol. 2019;68(2):263-278. https://doi.org/10.1099/jmm.0.000908

Diagne MM, Ndione MHD, Di Paola N, et al. Usutu virus Isolated from rodents in Senegal. Viruses. 2019;11(2):181. https://doi.org/10.3390/v11020181

Fan Y, Stronsky SM, Xu Y, et al. Multilamellar vaccine particle elicits potent immune activation with protein antigens and protects mice against Ebola virus infection. ACS Nano. 2019;13(10): 11087-11096. https://doi.org/10.1021/acsnano.9b03660

Fukuda H, Li S, Sardo L, et al. Structural determinants of the APOBEC3G N-terminal domain for HIV-1 RNA association. Front Cell Infect Microbiol. 2019;9:129. https://doi.org/10.3389/fcimb.2019.00129

Garrison AR, Smith DR, Golden JW. Animal models for Crimean-Congo hemorrhagic fever human disease. Viruses. 2019;11(7):590. https://doi.org/10.3390/v11070590

Golden JW, Shoemaker CJ, Lindquist ME, et al. GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection. Sci Adv. 2019;5(7):eaaw9535. https://doi.org/10.1126/sciadv.aaw9535

Grubaugh ND, Saraf S, Gangavarapu K, et al. Travel Surveillance and genomics uncover a hidden Zika outbreak during the waning epidemic. Cell. 2019;178(5):1057-1071.e1011. https://www.sciencedirect.com/science/article/pii/S0092867419307834?via%3Dihub

Happi AN, Happi CT, Schoepp RJ. Lassa fever diagnostics: past, present, and future. Curr Opin Virol. 2019;37:132-138. https://doi.org/10.1016/j.coviro.2019.08.002

Haston JC, Rostad CA, Jerris RC, et al. Prospective cohort study of next-generation sequencing as a diagnostic modality for unexplained encephalitis in children. J Pediatric Infect Dis Soc. 2019: piz032. https://doi.org/10.1093/jpids/piz032

Hogan M, Bahta M, Tsuji K, et al. Targeting protein-protein interactions of tyrosine phosphatases with microarrayed fragment libraries displayed on phosphopeptide substrate scaffolds. ACS Comb Sci. 2019;21(3):158-170. https://doi.org/10.1021/acscombsci.8b00122

Hulseberg CE, Fénéant L, Szymanska-De Wijs KM, et al. Arbidol and other low-molecular-weight drugs that inhibit Lassa and Ebola viruses. J Virol. 2019;93(8): e02185-18. https://doi.org/10.1128/JVI.02185-18

Jangra RK, Herbert AS, Li R, et al. Protocadherin-1 is essential for cell entry by New World hantaviruses. Nature. 2018;563(7732):559-563. https://doi.org/10.1038/s41586-018-0702-1

Jasenosky LD, Cadena C, Mire CE, et al. The FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits Ebola virus. iScience. 2019;19:1279-1290. https://doi.org/10.1016/j.isci.2019.07.003

Jiang JJ, Banglore P, Cashman KA, et al. Immunogenicity of a protective intradermal DNA vaccine against Lassa virus in cynomolgus macaques. Hum Vaccin Immunother. 2019;15(9):2066-2074. https://doi.org/10.1080/21645515.2019.1616499

Katawera V, Kohar H, Mahmoud N, et al. Enhancing laboratory capacity during Ebola virus disease (EVD) heightened surveillance in Liberia: lessons learned and recommendations. Pan Afr Med J. 2019;33(suppl 2):8. https://doi.org/10.11604/pamj.supp.2019.33.2.17366

Keasey SL, Smith JL, Fernandez S, Durbin AP, Zhao BM, Ulrich RG. Impact of Dengue virus serotype 2 strain diversity on serological immune responses to Dengue. ACS Infect Dis. 2018;4(12):1705-1717. https://doi.org/10.1021/acsinfecdis.8b00185

Keasey SL, Suh MJ, Das S, et al. Decreased antibiotic susceptibility driven by global remodeling of the klebsiella pneumoniae proteome. Mol Cell Proteomics. 2019;18(4):657-668. https://doi.org/10.1074/mcp.RA118.000739

Kende M, Paragas J, Salazar AM. The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys. Antiviral Res. 2019;163:179-184. https://doi.org/10.1016/j.antiviral.2018.12.020

Khan M, Miller C, Hale M. Development of an assay for antimicrobial susceptibility testing of Coxiella burnetii. Abstr Pap Am Chem Soc. 2019;257. https://mdsoar.org/handle/11603/13530

Kijek TM, Mou S, Bachert BA, et al. The D-alanyl-D-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge. Microb Pathog. 2019;137. https://doi.org/10.1016/j.micpath.2019.103742

Kim AS, Austin SK, Gardner CL, et al. Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein. Nat Microbiol. 2019;4(1):187-197+. https://doi.org/10.1038/s41564-018-0286-4

Kinoshita Y, Cloutier AK, Rozak DA, et al. A novel selective medium for the isolation of Burkholderia mallei from equine specimens. BMC Vet Res. 2019;15(1). https://doi.org/10.1186/s12917-019-1874-0

Ko SY, Akahata W, Yang ES, et al. A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates. Sci Transl Med. 2019;11(492). https://doi.org/10.1126/scitranslmed.aav3113

Koehler JW, Douglas CE, Minogue TD. A highly multiplexed broad pathogen detection assay for infectious disease diagnostics. PLoS Negl Trop Dis. 2018;12(11). https://doi.org/10.1371/journal.pntd.0006889

Krakauer T. Staphylococcal superantigens: Pyrogenic toxins induce toxic shock. Toxins (Basel). 2019;11(3):178. https://doi.org/10.3390/toxins11030178

Krishnamurthy M, Lemmon MM, Falcinelli EM, et al. Enhancing the antibacterial activity of polymyxins using a nonantibiotic drug. Infect Drug Resist. 2019;12:1393-1405. https://doi.org/10.2147/IDR.S196874

Kuhn JH, Amarasinghe GK, Basler CF, et al. ICTV virus taxonomy profile: Filoviridae. J Gen Virol. 2019;100(6):911-912. https://doi.org/10.1099/jgv.0.001252

Lindquist ME, Hicar MD. B Cells and antibodies in Kawasaki disease. Int J Mol Sci. 2019;20(8). https://doi.org/10.3390/ijms20081834

Liu J, Coffin KM, Johnston SC, et al. Nipah virus persists in the brains of nonhuman primate survivors. JCI Insight. 2019;4(14). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675545/

Maes P, Adkins S, Alkhovsky SV, et al. Taxonomy of the order Bunyavirales: second update 2018. Arch Virol. 2019;164(3):927-941. https://doi.org/10.1007/s00705-018-04127-3

Maes P, Amarasinghe GK, Ayllón MA, et al. Taxonomy of the order Mononegavirales: second update 2018. Arch Virol. 2019;164(4):1233-1244. https://doi.org/10.1007/s00705-018-04126-4

Martins KA, Gregory MK, Valdez SM, et al. Neutralizing antibodies from convalescent Chikungunya virus patients can cross-neutralize Mayaro and Una viruses. Am J Trop Med Hyg. 2019;100(6):1541-1544. https://doi.org/10.4269/ajtmh.18-0756

Maxson T, Blancett CD, Graham AS, Stefan CP, Minogue TD. Rapid antibiotic susceptibility testing from blood culture bottles with species agnostic real-time polymerase chain reaction. PLoS One. 2018;13(12):e0209042. https://doi.org/10.1371/journal.pone.0209042

Mbala-Kingebeni P, Aziza A, Di Paola N, et al. Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri provinces of the Democratic Republic of the Congo: a rapid genomic assessment. Lancet Infect Dis. 2019;19(6):648-657. https://doi.org/10.1016/S1473-3099(19)30118-5

Mbala-Kingebeni P, Pratt CB, Wiley MR, et al. 2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation. Lancet Infect Dis. 2019;19(6):641-647. https://doi.org/10.1016/S1473-3099(19)30124-0

McCall S, Kreindl G, Kastinger T, et al. Rudolf Hess - The Doppelganger conspiracy theory disproved. Forensic Sci Int Genet2019;40:18-22. https://doi.org/10.1016/j.fsigen.2019.01.004

Minogue TD, Koehler JW, Stefan CP, Conrad TA. Next-generation sequencing for biodefense: biothreat detection, forensics, and the clinic. Clin Chem. 2019;65(3):383-392. https://doi.org/10.1373/clinchem.2016.266536

Mohamed YF, Scott NE, Molinaro A, et al. A general protein O-glycosylation machinery conserved in Burkholderia species improves bacterial fitness and elicits glycan immunogenicity in humans. J Biol Chem. 2019;294(36):13248-13268. https://doi.org/10.1074/jbc.RA119.009671

Morazzani EM, Compton JR, Leary DH, et al. Proteolytic cleavage of host proteins by the group IV viral proteases of Venezuelan equine encephalitis virus and Zika virus. Antiviral Res. 2019;164:106-122. https://doi.org/10.1016/j.antiviral.2019.02.001

Morwitzer MJ, Tritsch SR, Cazares LH, et al. Identification of RUVBL1 and RUVBL2 as novel cellular interactors of the Ebola virus nucleoprotein. Viruses. 2019;11(4):pii: E372. https://doi.org/10.3390/v11040372

Nalca A, Totura A, Livingston V, Frick O, Dyer D. African green monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Int J Infect Dis. 2019;79(suppl 1):99-100. https://doi.org/10.1016/j.ijid.2018.11.249

Natesan M, Wu SW, Chen CI, et al. A smartphone-based rapid telemonitoring system for Ebola and Marburg isease surveillance. ACS Sens. 2019;4(1):61-68. https://doi.org/10.1021/acssensors.8b00842

Nimo-Paintsil SC, Fichet-Calvet E, Borremans B, et al. Rodent-borne infections in rural Ghanaian farming communities [published correction appears in PLoS One. 2019;14(6): e0218271]. PLoS One. 2019;14(4): e0215224. https://doi.org/10.1371/journal.pone.0215224

Nunes MRT, de Souza WM, Savji N, et al. Oropouche orthobunyavirus: genetic characterization of full-length genomes and development of molecular methods to discriminate natural reassortments. Infect Genet Evol. 2019;68:16-22. https://doi.org/10.1016/j.meegid.2018.11.020

Obregon-Perko V, Parodi L, Hodara V, et al. Adaptation of SIV to baboon PBMC or isolated CD4 cells: insights into cell types required for baboon resistance to SIV infection. J Med Primatol. 2018;47(5)(Special Issue: 35th Annual Symposium on Nonhuman Primate Models for AIDS):323-323. https://doi.org/10.1111/jmp.12383

Oliveira DBL, Durigon GS, Mendes É, et al. Persistence and intra-host genetic evolution of Zika virus infection in symptomatic adults: a special view in the male reproductive system. Viruses. 2018;10(11). https://doi.org/10.3390/v10110615

Olson MA. Conformational selection of a polyproline peptide by Ebola virus VP30. Proteomics. 2018;18(21-22):e1800081. https://doi.org/10.1002/pmic.201800081

Olson MA, Legler PM, Zabetakis D, Turner KB, Anderson GP, Goldman ER. Sequence tolerance of a single-domain antibody with a high thermal stability: comparison of computational and experimental fitness profiles. ACS Omega. 2019;4(6):10444-10454. https://doi.org/10.1021/acsomega.9b00730

Pandya UM, Egbuta C, Norman TMA, et al. The biophysical interaction of the danger-associated molecular pattern (DAMP) calreticulin with the pattern-associated molecular pattern (PAMP) lipopolysaccharide. Int J Mol Sci. 2019;20(2):408. https://doi.org/10.3390/ijms20020408

Perez-Sautu U, Wiley MR, Iglesias-Caballero M, et al. Target-independent high-throughput sequencing methods provide evidence that already known human viral pathogens play a main role in respiratory infections with unexplained etiology. Emerg Microbes Infect. 2019;8(1):1054-1065. https://doi.org/10.1080/22221751.2019.1640587

Perley CC, Brocato RL, Kwilas SA, et al. Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses. PLoS One. 2019;14(5):e0216700. https://doi.org/10.1371/journal.pone.0216700

Pessi A, Bixler SL, Soloveva V, et al. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo. Antiviral Res. 2019;171:104592. https://doi.org/10.1016/j.antiviral.2019.104592

Pleet ML, DeMarino C, Stonier SW, et al. Extracellular vesicles and Ebola virus: a new mechanism of immune evasion. Viruses. 2019;11(5):pii E40. https://doi.org/10.3390/v11050410

Rajamani S, Sandy R, Kota K, et al. Robust biofilm assay for quantification and high throughput screening applications. J Microbiol Methods. 2019;159:179-185. https://doi.org/10.1016/j.mimet.2019.02.018

Ramirez de Arellano E, Sanchez-Lockhart M, Perteguer MJ, et al. First evidence of antibodies against Lloviu virus in Schreiber's bent-winged insectivorous bats demonstrate a wide circulation of the virus in Spain. Viruses. 2019;11(4):pii E60. https://doi.org/10.3390/v11040360

Ricks KM, Koehler J, Shoemaker C, Voorhees M, Schoepp R. Development of a sustainable diagnostic toolbox for serosurveillance of West African infectious diseases. Int J Infect Dis. 2019(suppl 1);79:24-25. https://doi.org/10.1016/j.ijid.2018.11.074

Ricks KM, Shoemaker CJ, Dupuy LC, et al. Development of a bead-based immunoassay using virus-like particles for detection of alphaviral humoral response. J Virol Methods. 2019;270:12-17. https://doi.org/10.1016/j.jviromet.2019.04.013

Rusnak JM, Dupuy LC, Niemuth NA, Glenn AM, Ward LA. Comparison of aerosol- and percutaneous-acquired Venezuelan equine encephalitis in humans and nonhuman primates for suitability in predicting clinical efficacy under the animal rule. Comp Med. 2018;68(5):380-395. https://doi.org/10.30802/AALAS-CM-18-000027

Rusnak JM, Glass PJ, Weaver SC, et al. Approach to strain selection and the propagation of viral stocks for Venezuelan equine encephalitis virus vaccine efficacy testing under the animal rule. Viruses. 2019;11(9):pii E807. https://doi.org/10.3390/v11090807

Saikh KU, Dankmeyer JL, Zeng X, Ulrich RG, Amemiya K. An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency. Immun Inflamm Dis. 2019;7(1):7-21. https://doi.org/10.1002/iid3.239

Salami K, Gouglas D, Schmaljohn C, Saville M, Tornieporth N. A review of Lassa fever vaccine candidates. Curr Opin Virol. 2019;37:105-111. https://doi.org/10.1016/j.coviro.2019.07.006

Samsa MM, Dupuy LC, Beard CW, et al. Self-amplifying RNA vaccines for Venezuelan equine encephalitis virus induce robust protective immunogenicity in mice. Mol Ther. 2019;27(4):850-865. https://doi.org/10.1016/j.ymthe.2018.12.013

Scarff JM, Waidyarachchi SL, Meyer CJ, et al. Aminomethyl spectinomycins: a novel antibacterial chemotype for biothreat pathogens. J Antibiot (Tokyo). 2019;72(9):693-701. https://doi.org/10.1038/s41429-019-0194-8

Schmaljohn C, Safronetz D. Editorial overview: Lassa virus. Curr Opin Virol. 2019;37:vii-ix. https://doi.org/10.1016/j.coviro.2019.09.001  

Selakovic Ž, Tran JP, Kota KP, et al. Second generation of diazachrysenes: protection of Ebola virus infected mice and mechanism of action. Eur J Med Chem. 2019;162:32-50. https://doi.org/10.1016/j.ejmech.2018.10.061

Si LL, Meng K, Tian ZY, et al. Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes. Sci Adv. 2018;4(11):eaau8408. https://doi.org/10.1126/sciadv.aau8408

Sichtig H, Minogue T, Yan Y, et al. FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science. Nat Commun. 2019;10(1):3313. https://doi.org/10.1038/s41467-019-11306-6

Siddharthan V, Miao J, Van Wettere AJ, et al. Human polyclonal antibodies produced from transchromosomal bovine provides prophylactic and therapeutic protections against Zika virus infection in STAT2 KO Syrian hamsters. Viruses. 2019;11(2):pii E92. https://doi.org/10.3390/v11020092

Smith D, Shoemaker CJ, Garrison A, et al. The pathogenesis of genetically diverse strains of Crimean-Congo hemorrhagic fever virus in the cynomolgus macaque model. Int J Infect Dis. 2019;79(suppl 1):16. https://doi.org/10.1016/j.ijid.2018.11.056

Smith DR, Shoemaker CJ, Zeng X, et al. Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis. PLoS Pathog. 2019;15(9):e1008050. https://doi.org/10.1371/journal.ppat.1008050

Sobarzo A, Stonier SW, Radinsky O, et al. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors. EBioMedicine. 2019;46:215-226. https://doi.org/10.1016/j.ebiom.2019.07.021

Steger CL, Brown ML, Sullivan OM, et al. In vitro double-stranded RNA synthesis by rotavirus polymerase mutants with lesions at core shell contact sites. J Virol. 2019;93(20):pii e01049. https://doi.org/10.1128/JVI.01049-19

Totura AL, Bavari S. Broad-spectrum coronavirus antiviral drug discovery. Expert Opin Drug Discov. 2019;14(4):397-412. https://doi.org/10.1080/17460441.2019.1581171

Trevino SR, Klimko CP, Reed MC, et al. Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei. PLoS One. 2018;13(11):e0208277. https://doi.org/10.1371/journal.pone.0208277

Turell MJ, Gozalo AS, Guevara C, et al. Lack of evidence of sylvatic transmission of dengue viruses in the Amazon Rainforest near Iquitos, Peru. Vector Borne Zoonotic Dis. 2019;19(9):685-689. https://doi.org/10.1089/vbz.2018.2408

Turner MJ, Cox JK, Spellman AC, Stahl C, Bavari S. Avoidance behavior independent of innate-immune signaling seen in Caenorhabditis elegans challenged with Bacillus anthracis. Dev Comp Immunol. 2020;102:103453. https://doi.org/10.1016/j.dci.2019.103453

Verdonck S, Pu SY, Sorrell FJ, et al. Synthesis and structure-activity relationships of 3,5-disubstituted-pyrrolo 2,3-b pyridines as Inhibitors of adaptor-associated kinase 1 with antiviral activity. J Med Chem. 2019;62(12):5810-5831. https://doi.org/10.1021/acs.jmedchem.9b00136

Voorhees M, Ricks KM, Fulmer A, Quesinberry J, Poli M, Schoepp R. Development of a multiplexed antigen detection immunoassay for detection of viral agents. Int J Infect Dis. 2019;79(suppl 1):106. https://doi.org/10.1016/j.ijid.2018.11.264

Voorhees MA, Padilla SL, Jamsransuren D, et al. Crimean-Congo hemorrhagic fever virus, Mongolia, 2013-2014. Emerg Infect Dis. 2018;24(12):2202-2209. https://doi.org/10.3201/eid2412.180175

Ward MD, Brueggemann EE, Kenny T, et al. Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison. Clin Proteomics. 2019;16. https://doi.org/10.1186/s12014-019-9227-3

Wec AZ, Bornholdt ZA, He S, et al. Development of a human antibody cocktail that deploys multiple functions to confer pan-Ebolavirus protection. Cell Host Microbe. 2019;25(1):39-48.e35. https://doi.org/10.1016/j.chom.2018.12.004

West BR, Wec AZ, Moyer CL, et al. Structural basis of broad ebolavirus neutralization by a human survivor antibody. Nat Struct Mol Biol. 2019;26(3):204-212. https://doi.org/10.1038/s41594-019-0191-4

Williamson LE, Flyak AI, Kose N, et al. Early human B cell response to Ebola virus in four U.S. survivors of infection. J Virol. 2019;93(8):pii e01439-18. https://doi.org/10.1128/JVI.01439-18

Zabetakis D, Shriver-Lake LC, Olson MA, Goldman ER, Anderson GP. Experimental evaluation of single-domain antibodies predicted by molecular dynamics simulations to have elevated thermal stability. Protein Sci. 2019;28(10):1909-1912. https://doi.org/10.1002/pro.3692